# Mental health clinicians’ perceptions on patient motivations and intervention engagement for prenatal cannabis use: A mixed methods study

## TL;DR

This study explores how mental health clinicians perceive and address prenatal cannabis use, focusing on patient motivations and engagement strategies.

## Contribution

The study provides new insights into clinicians' approaches to prenatal cannabis use, emphasizing patient-centered methods and readiness to engage.

## Key findings

- Clinicians perceive nausea/morning sickness as the main motive for prenatal cannabis use.
- Motivational interviewing and harm reduction are commonly used to address cannabis use.
- Patient readiness and therapeutic rapport are key facilitators for engagement.

## Abstract

Mental health clinicians are uniquely suited to support and provide important insights about substance use among pregnant patients. This mixed-methods study explored how mental health clinicians perceive and address prenatal cannabis use.

Participants were licensed mental health clinicians from Kaiser Permanente Northern California’s Early Start perinatal substance use screening and counseling program. Participants aimed to support patients’ goals for a healthy pregnancy. ESS completed a survey (N = 26; 100 % Female; 73.1 % White; Mage=48.1) and semi-structured interview (n = 14) on their perceptions about patients’ prenatal cannabis use and engagement in the ES program. Interviews were recorded, transcribed coded, and thematically analyzed.

Survey results indicated clinicians perceive that nausea/morning sickness was the most common motive for prenatal cannabis use, and pregnant individuals were most likely to get information about prenatal cannabis use from their peers. Survey and interview results indicated clinicians most often used motivational interviewing, harm reduction, and psychoeducation to address cannabis use. Clinicians reported on psychotherapeutic factors (patient readiness, therapeutic rapport, and mental health support) that facilitate engagement and willingness to quit and/or reduce cannabis use during pregnancy. Other themes included ESS utilization of expertise in complementary mental health topics to support their work.

In this mixed-methods study, clinicians described several approaches to increase pregnant patients’ willingness to engage in perinatal substance use interventions, including eliciting motives for cannabis use and using patient-centered interventions focused on establishing rapport and addressing readiness to quit. Future interventions for patients might incorporate harm reduction and psychoeducation, address motivations for use and readiness to engage in care, emphasize peer support, and support the implementation of complementary interventions.

•Mental health clinicians report on prenatal cannabis use intervention engagement.•Clinicians use MI, harm reduction, and psychoeducation for prenatal cannabis use.•Patient readiness, rapport, and mental health support are facilitators.•Clinicians utilize complementary mental health expertise to support their work.

Mental health clinicians report on prenatal cannabis use intervention engagement.

Clinicians use MI, harm reduction, and psychoeducation for prenatal cannabis use.

Patient readiness, rapport, and mental health support are facilitators.

Clinicians utilize complementary mental health expertise to support their work.